85-4494-37　VEGF165, Recombinant, Human, aa207-370 (Vascular endothelial growth factor A , VEGF, MVCD1, VPF) 50ug　351573

特徴

• Vascular endothelial growth factor (VEGF) is homodimeric, heparin-binding glycoprotein involved in both angiogenesis and vasculogenesis. VEGF is expressed as multiple alternately spliced isoforms of VEGF121, 165, 189 and 206. VEGF binds to the receptor tyrosine kinases VEGF R1 (Flt-1) and VEGF R2 (KDR/Flk-1) to activate signal transduction and regulate both physiological and pathological angiogenesis.
• Source:Recombinant protein corresponding to aa207-370 from human VEGF165 expressed in E. coli.
• Molecular Weight:~19.3kD(166aa)
• AA Sequence:MAPMAEGGGQ NHHEVVKFMD VYQRSYCHPI ETLVDIFQEY PDEIEYIFKP SCVPLMRCGG CCNDEGLECV PTEESNITMQ IMRIKPHQGQ HIGEMSFLQH NKCECRPKKD RARQENPCGP CSERRKHLFV QDPQTCKCSC KNTDSRCKAR QLELNERTCR CDKPRR
• Storage and Stability:May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

仕様

• Size：50ug
• Source Antigen：Recombinant, human from E. coli
• Grade：Purified
• Purity：~90% (SDS-PAGE)
• Form：Supplied as a liquid in 20mM Tris-HCl, pH 8.0, 2mM EDTA, 0.1mM PMSF, 1mM DTT, 10% glycerol.
• Molecular Weight Non Ab：19.3
• EU Commodity Code：30021019
• この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
• 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。

• 【試薬に関するお問合せ】
• アズワン株式会社 試薬・プロセス材料グループ
• TEL：06-6447-8641
• FAX：06-6447-8642
• E-mail：[email protected]